Cargando…
Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer
BACKGROUND: Tissue biopsy is an integral part of the diagnostic approach to lung cancer. It is however invasive and limited by heterogeneity. Liquid biopsies may complement tissue testing by providing additional molecular information and may be particularly helpful in patients from whom obtaining su...
Autores principales: | Choudhury, Yukti, Tan, Min-Han, Shi, Jun Li, Tee, Augustine, Ngeow, Kao Chin, Poh, Jonathan, Goh, Ruth Rosalyn, Mong, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873935/ https://www.ncbi.nlm.nih.gov/pubmed/35223889 http://dx.doi.org/10.3389/fmed.2022.758464 |
Ejemplares similares
-
Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA
por: Poh, Jonathan, et al.
Publicado: (2022) -
Crafting Care That Fits: Workload and Capacity Assessments Complementing Decision Aids in Implementing Shared Decision Making
por: Wieringa, Thomas H, et al.
Publicado: (2020) -
Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017) -
Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017) -
‘But what if you miss something …?’: factors that influence medical student consideration of cost in decision making
por: Tan, Emmanuel, et al.
Publicado: (2023)